Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Alibaba Health Information Technology ( (HK:0241) ).
Alibaba Health Information Technology Limited has announced a special general meeting to be held on December 30, 2025, to discuss and potentially approve revised annual caps for its marketing and promotion services framework agreement with Hangzhou Alimama Software Services Co., Ltd. The proposed caps are set at RMB3,600,000 for the year ending March 31, 2026, and RMB4,800,000 for the year ending March 31, 2027. This move is likely to impact the company’s marketing strategies and financial planning, potentially enhancing its market presence and operational efficiency.
The most recent analyst rating on (HK:0241) stock is a Hold with a HK$5.20 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited operates in the healthcare industry, focusing on providing digital health services and solutions. The company is known for its integration of technology with healthcare, offering services such as online medical consultations, pharmaceutical e-commerce, and health management solutions.
YTD Price Performance: 63.86%
Average Trading Volume: 95,315,780
Technical Sentiment Signal: Hold
Current Market Cap: HK$87.96B
For a thorough assessment of 0241 stock, go to TipRanks’ Stock Analysis page.